[go: up one dir, main page]

FR2918277B1 - Nouveau procede de production de formes pharmaceutiques seches hydrodispersibles et les compositions hydrodispersibles ainsi obtenues - Google Patents

Nouveau procede de production de formes pharmaceutiques seches hydrodispersibles et les compositions hydrodispersibles ainsi obtenues

Info

Publication number
FR2918277B1
FR2918277B1 FR0704874A FR0704874A FR2918277B1 FR 2918277 B1 FR2918277 B1 FR 2918277B1 FR 0704874 A FR0704874 A FR 0704874A FR 0704874 A FR0704874 A FR 0704874A FR 2918277 B1 FR2918277 B1 FR 2918277B1
Authority
FR
France
Prior art keywords
hydrodispersible
compositions
production
novel process
pharmaceutical forms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0704874A
Other languages
English (en)
Other versions
FR2918277A1 (fr
Inventor
Patrice Binay
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CORETECHOLDING
Original Assignee
CORETECHOLDING
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0704874A priority Critical patent/FR2918277B1/fr
Application filed by CORETECHOLDING filed Critical CORETECHOLDING
Priority to BRPI0814027-8A2A priority patent/BRPI0814027A2/pt
Priority to EP08827662A priority patent/EP2192894A2/fr
Priority to CA2694059A priority patent/CA2694059A1/fr
Priority to KR1020107000196A priority patent/KR20100038188A/ko
Priority to JP2010514045A priority patent/JP5560188B2/ja
Priority to US12/452,543 priority patent/US20130064897A1/en
Priority to RU2010103999/15A priority patent/RU2497502C2/ru
Priority to PCT/FR2008/000973 priority patent/WO2009024686A2/fr
Publication of FR2918277A1 publication Critical patent/FR2918277A1/fr
Application granted granted Critical
Publication of FR2918277B1 publication Critical patent/FR2918277B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR0704874A 2007-07-06 2007-07-06 Nouveau procede de production de formes pharmaceutiques seches hydrodispersibles et les compositions hydrodispersibles ainsi obtenues Expired - Fee Related FR2918277B1 (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
FR0704874A FR2918277B1 (fr) 2007-07-06 2007-07-06 Nouveau procede de production de formes pharmaceutiques seches hydrodispersibles et les compositions hydrodispersibles ainsi obtenues
EP08827662A EP2192894A2 (fr) 2007-07-06 2008-07-07 Procede de production de formes pharmaceutiques seches hydrodispersibles
CA2694059A CA2694059A1 (fr) 2007-07-06 2008-07-07 Nouveau procede de production de formes pharmaceutiques seches hydrodispersibles et les compositions pharmaceutiques ainsi obtenues
KR1020107000196A KR20100038188A (ko) 2007-07-06 2008-07-07 수분산성 건성 약학적 조성물의 신규 제조 방법 및 그에 의해 수득한 약학적 조성물
BRPI0814027-8A2A BRPI0814027A2 (pt) 2007-07-06 2008-07-07 Processo de produção de formas farmacêuticas secas hidrodispersíveis
JP2010514045A JP5560188B2 (ja) 2007-07-06 2008-07-07 水分散性の乾いた形態の医薬品の新規製造方法およびそれに伴い得られる医薬組成物
US12/452,543 US20130064897A1 (en) 2007-07-06 2008-07-07 New process for producing hydrodispexible dry pharmaceutical composition and the pharmaceutical compositions thus obtained
RU2010103999/15A RU2497502C2 (ru) 2007-07-06 2008-07-07 Новый способ получения сухих фармацевтических форм, диспергируемых в воде, и фармацевтические композиции, полученные таким способом
PCT/FR2008/000973 WO2009024686A2 (fr) 2007-07-06 2008-07-07 Procede de production de formes pharmaceutiques seches hydrodispersibles

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0704874A FR2918277B1 (fr) 2007-07-06 2007-07-06 Nouveau procede de production de formes pharmaceutiques seches hydrodispersibles et les compositions hydrodispersibles ainsi obtenues

Publications (2)

Publication Number Publication Date
FR2918277A1 FR2918277A1 (fr) 2009-01-09
FR2918277B1 true FR2918277B1 (fr) 2012-10-05

Family

ID=39469562

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0704874A Expired - Fee Related FR2918277B1 (fr) 2007-07-06 2007-07-06 Nouveau procede de production de formes pharmaceutiques seches hydrodispersibles et les compositions hydrodispersibles ainsi obtenues

Country Status (9)

Country Link
US (1) US20130064897A1 (fr)
EP (1) EP2192894A2 (fr)
JP (1) JP5560188B2 (fr)
KR (1) KR20100038188A (fr)
BR (1) BRPI0814027A2 (fr)
CA (1) CA2694059A1 (fr)
FR (1) FR2918277B1 (fr)
RU (1) RU2497502C2 (fr)
WO (1) WO2009024686A2 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
PT2782584T (pt) 2011-11-23 2021-09-02 Therapeuticsmd Inc Preparações e terapias de substituição para hormonoterapias naturais combinadas
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10206932B2 (en) 2014-05-22 2019-02-19 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
MX2018011705A (es) 2016-04-01 2019-06-10 Therapeuticsmd Inc Composicion farmaceutica de hormona esteroide.

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9003296L (sv) * 1990-10-16 1992-04-17 Kabi Pharmacia Ab Foerfarande foer att formulera laekemedel
FR2722984B1 (fr) 1994-07-26 1996-10-18 Effik Lab Procede de preparation de formes pharmaceutiques seches et les compositions pharmaceutiques ainsi realisees
US6248363B1 (en) 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US20030180352A1 (en) * 1999-11-23 2003-09-25 Patel Mahesh V. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
EP1239844B1 (fr) * 1999-12-20 2005-06-08 Nicholas J. Kerkhof Procede de production de particules d'echelle nanometrique par sechage par atomisation en lit fluidise
DE10244681A1 (de) * 2002-09-24 2004-04-08 Boehringer Ingelheim International Gmbh Neue feste Telmisartan enthaltende pharmazeutische Formulierungen und deren Herstellung
US20040185170A1 (en) * 2003-03-21 2004-09-23 Shubha Chungi Method for coating drug-containing particles and formulations and dosage units formed therefrom
KR20060085686A (ko) 2003-10-10 2006-07-27 라이프사이클 파마 에이/에스 피브레이트를 포함하는 고형 제제
US20050181049A1 (en) * 2003-11-19 2005-08-18 Dong Liang C. Composition and method for enhancing bioavailability
KR100629771B1 (ko) * 2004-01-27 2006-09-28 씨제이 주식회사 결정성이 감소되거나 무정형화된 올티프라즈의 제조방법
US7635745B2 (en) * 2006-01-31 2009-12-22 Eastman Chemical Company Sulfopolyester recovery

Also Published As

Publication number Publication date
CA2694059A1 (fr) 2009-02-26
US20130064897A1 (en) 2013-03-14
BRPI0814027A2 (pt) 2015-02-03
RU2497502C2 (ru) 2013-11-10
JP5560188B2 (ja) 2014-07-23
WO2009024686A3 (fr) 2009-04-23
EP2192894A2 (fr) 2010-06-09
JP2010532336A (ja) 2010-10-07
WO2009024686A2 (fr) 2009-02-26
FR2918277A1 (fr) 2009-01-09
KR20100038188A (ko) 2010-04-13
RU2010103999A (ru) 2011-08-20

Similar Documents

Publication Publication Date Title
FR2918277B1 (fr) Nouveau procede de production de formes pharmaceutiques seches hydrodispersibles et les compositions hydrodispersibles ainsi obtenues
FR2912751B1 (fr) Procede de preparation de polylactones et polylactames
FI20070569A0 (fi) Uusi stabiili tuote ja menetelmä sen valmistamiseksi
BRPI1012875A2 (pt) composições farmacêuticas sólidas e processos para sua produção
BRPI0916862A2 (pt) compostos úteis para o tratamento de doenças degenerativas e inflamatórias
EP2167511A4 (fr) Préparation de structures zéolithiques fonctionnalisées
BRPI1012116A2 (pt) composição farmacêutica para o tratamento de doenças cardíacas
FR2943660B1 (fr) Procede d'elaboration de graphene
FR2916974B1 (fr) Procede de preparation de nanoparticules lipidiques
FR2918990B1 (fr) Procede de preparation de compositions pulverulentes stables
FR2934857B1 (fr) Nouveau procede de synthese de l'agomelatine
FR2962731B1 (fr) Procede de preparation de derives d'amino-benzoyl-benzofurane
EP2412706A4 (fr) Nouveau dérivé hydroxamate, procédé de production associé, et composition pharmaceutique comprenant le dérivé
FR2920773B1 (fr) Derives de 1,2,4,5-tetrahydro-3h-benzazepines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2950889B1 (fr) Procede de synthese de l'ergothioneine et analogues
BRPI0813100A2 (pt) Preparação sólida farmacêutica e método de produção da mesma
FR2934859B1 (fr) Nouveau procede de synthese de l'agomelatine
EP2341773A4 (fr) Compositions pharmaceutiques d atorvastatine
FI20095500A0 (fi) Tuote ja menetelmä sen valmistamiseksi
FR2923484B1 (fr) Procede de preparation de composes morphiniques
FI20070395A (fi) Fotokatalyyttisesti aktiivinen koostumus ja menetelmä sen valmistamiseksi
FR2955329B1 (fr) Procede de preparation de compositions thermoplastiques a base d'amidon plastifie et compositions
BRPI0818702A2 (pt) Formulação farmacêutica de ácido clavulânico
FR2939795B1 (fr) Procede de preparation d'esters actives
EP2400848A4 (fr) Cristallisation de composés pharmaceutiques

Legal Events

Date Code Title Description
TP Transmission of property
PLFP Fee payment

Year of fee payment: 9

ST Notification of lapse

Effective date: 20170331